Cotec Healthcare IPO - Date, Price Band & Details

Incorporated in 1998, Cotec Healthcare Limited has established itself as a major force in India’s pharmaceutical Contract Development and Manufacturing Organisation (CDMO) landscape. Headquartered in Roorkee, Uttarakhand, the company operates within a highly supportive regional pharmaceutical ecosystem. Cotec specialises in the development, loan licensing, and commercial manufacturing of off-patent pharmaceutical formulations and complex generics, delivering high-quality medicinal solutions to both institutional and private healthcare clients.
The company stands out for its extensive manufacturing capabilities, ranking as one of the country's leading CDMO players by the sheer diversity of its offerings. Cotec is equipped to produce 24 distinct formulation types across various delivery systems. Its comprehensive portfolio spans critical medical formats, including tablets, capsules, injectables, ointments, eye drops, ampoules, vials, infusions, and both liquid and dry syrups.
Driven by strong promoters Harsh Tiwari and Vandana Tiwari, Cotec Healthcare is executing a strategic transition toward high-value products and specialized therapeutic segments. To sustain its rapid growth, the company is actively expanding its manufacturing footprint in Uttarakhand. This expansion includes creating specialized, dedicated production lines for penicillin, advanced oncology drugs, and sterile small-volume parenterals (SVP), ensuring the company remains at the forefront of affordable healthcare manufacturing.